We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
USA - April 23 2012
Over the last decade, drug, device, and biotechnology companies have taken their demand for clinical trial work to the global marketplace — vastly increasing the number of trials taking place outside of the United States.
